| Date Filed | Type | Description |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/09/2023 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on HilleVax, Inc.|
Txns:
| Granted 22,500 options
@ $17.94, valued at
$403.7k
|
|
| 06/09/2023 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 12,554 options to buy
@ $48.66, valued at
$610.9k
|
|
| 08/23/2022 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on HilleVax, Inc.|
Txns:
| Granted 25,000 options
@ $12.38, valued at
$309.5k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 407 shares
@ $69.61, valued at
$28.3k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 8,700 options to buy
@ $77.25, valued at
$672.1k
|
|
| 04/28/2022 |
3
| HILLEMAN JERYL L (Director) has filed a Form 3 on HilleVax, Inc. |
| 06/28/2021 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on SI-BONE, Inc.|
Txns:
| Sold 4,400 shares
@ $33.71, valued at
$148.3k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on SI-BONE, Inc.|
Txns:
| Granted 3,848 shares
@ $0 |
|
| 06/11/2021 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 814 restricted stock units
@ $0
Disposed/sold 1,270 shares
@ $210.01, valued at
$266.7k
Granted 1,499 options to buy
@ $211.89, valued at
$317.6k
|
|
| 03/18/2021 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on Talis Biomedical Corp|
Txns:
| Granted 35,112 options to buy
@ $17.6, valued at
$618k
|
|
| 03/18/2021 |
3
| HILLEMAN JERYL L (Director) has filed a Form 3 on Talis Biomedical Corp |
| 12/22/2020 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 2,500 restricted stock units
@ $166.4, valued at
$416k
|
|
| 06/18/2020 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on SI-BONE, Inc.|
Txns:
| Granted 8,797 shares
@ $0 |
|
| 06/12/2020 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 2,541 restricted stock units
@ $0
Granted 5,101 options to buy
@ $67.89, valued at
$346.3k
|
|
| 06/12/2020 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.4, valued at
$68k
|
|
| 12/04/2019 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on SI-BONE, Inc.|
Txns:
| Granted 26,236 options to buy
@ $17.31, valued at
$454.1k
|
|
| 12/04/2019 |
3
| HILLEMAN JERYL L (Director) has filed a Form 3 on SI-BONE, Inc. |
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2019 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on Minerva Neurosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.21, valued at
$104.2k
|
|
| 05/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/08/2019 |
4
| HILLEMAN JERYL L (CFO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 11,952 shares
@ $0 |
|
| 04/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| HILLEMAN JERYL L (CFO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Granted 12,000 shares
@ $0
Granted 56,000 options to buy
@ $28.58, valued at
$1.6M
|
|
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2018 |
4
| HILLEMAN JERYL L (CFO) has filed a Form 4 on Intersect ENT, Inc.|
Txns:
| Sold 12,833 shares
@ $28.9224, valued at
$371.2k
Exercised 12,833 options to buy
@ $11.12, valued at
$142.7k
|
|
| 08/06/2018 |
3
| HILLEMAN JERYL L (Director) has filed a Form 3 on NovoCure Ltd |
| 08/02/2018 |
4
| HILLEMAN JERYL L (Director) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 37,101 options to buy
@ $34, valued at
$1.3M
|
|
|